WO2023147946 - BIOMARKERS OF CARDIOVASCULAR DISEASE

National phase entry:
Publication Number WO/2023/147946
Publication Date 10.08.2023
International Application No. PCT/EP2023/025053
International Filing Date 06.02.2023
Title **
[English] BIOMARKERS OF CARDIOVASCULAR DISEASE
[French] BIOMARQUEURS DE MALADIE CARDIOVASCULAIRE
Applicants **
RANDOX LABORATORIES LTD 55 Diamond Road Crumlin Country Antrim BT29 4 QY, GB
Inventors
INNOCENZI, Paul John Randox Laboratories Ltd 55 Diamond Road Crumlin BT29 4QY, GB
FITZGERALD, Peter Randox Laboratories Ltd 55 Diamond Road Crumlin BT29 4QY, GB
MCCONNELL, Ivan Randox Laboratories Ltd 55 Diamond Road Crumlin BT29 4QY, GB
Priority Data
2201531.7   07.02.2022   GB
front page image
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
*
International Searching Authority
*
Applicant's Legal Status
*
*
*
*
*
Entry into National Phase under
*
Translation

Recalculate

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing1101
EPO Filing, Examination4635
Japan Filing594
South Korea Filing575
USA Filing, Examination3310
MasterCard Visa

Total: 10215

The term for entry into the National Phase has expired. This quotation is for informational purposes only

Abstract[English] Methods relating to standard clinical biomarkers for use in the diagnosis of angina are described.[French] L'invention concerne des procédés se rapportant à des biomarqueurs cliniques standard destinés à être utilisés dans le diagnostic de l'angine de poitrine.
An unhandled error has occurred. Reload 🗙